---
title: "The Oncology Institute, Inc. (TOI.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TOI.US.md"
symbol: "TOI.US"
name: "The Oncology Institute, Inc."
industry: "Health Care Facilities"
datetime: "2026-06-13T23:37:18.305Z"
locales:
  - [en](https://longbridge.com/en/quote/TOI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TOI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TOI.US.md)
---

# The Oncology Institute, Inc. (TOI.US)

## Company Overview

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies.

| Item | Detail |
|------|--------|
| Industry | Health Care Facilities |
| Exchange | US Market |
| Website | [eoncologyinstitute.com](https://eoncologyinstitute.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-13T04:30:12.000Z

**Overall: B (0.38)**

**Industry**: Health Care Facilities

| Metric | Value |
|--------|-------|
| Industry Ranking | 10 / 25 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 35.37% |  |
| Net Profit YoY | 31.21% |  |
| P/B Ratio | -32.60 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 530909374.23 |  |
| Revenue | 545764000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 647.72% | A |
| Profit Margin | -7.97% | D |
| Gross Margin | 15.81% | D |
| Revenue YoY | 35.37% | A |
| Net Profit YoY | 31.21% | B |
| Total Assets YoY | 2.58% | C |
| Net Assets YoY | -421.27% | E |
| Cash Flow Margin | 60.05% | C |
| OCF YoY | 35.37% | A |
| Turnover | 3.29 | A |
| Gearing Ratio | 109.68% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - The Oncology Institute, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "35.37%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "31.21%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-32.60",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "530909374.23",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "545764000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "647.72%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-7.97%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "15.81%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "35.37%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "31.21%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.58%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-421.27%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "60.05%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "35.37%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "3.29",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "109.68%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -14.62 | 20/25 | - | - | - |
| PB | -32.60 | 21/25 | 66.36 | 55.68 | 42.34 |
| PS (TTM) | 0.97 | 11/25 | 0.84 | 0.73 | 0.61 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Encompass Health (EHC.US) | A | B | B | C | B | B |
| 02 | Universal Health Service-B (UHS.US) | B | B | A | C | B | B |
| 03 | Ensign (ENSG.US) | B | B | A | D | B | B |
| 04 | PACS (PACS.US) | B | A | A | E | B | B |
| 05 | Concentra Group Holdings Parent (CON.US) | B | B | B | E | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-06-08T04:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 75% |
| Overweight | 1 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.31 |
| Highest Target | 8.00 |
| Lowest Target | 5.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TOI.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TOI.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TOI.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TOI.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**